Institutional Ownership
Kyverna Therapeutics Inc
CUSIP 501976104COMKYTXQ1 2026
Institutional Holders
107
13F filers
Shares Held
32.75M
Aggregate institutional
Institutional Value
$269.10M
Q1 2026
Net New Holders
+11
23 new · 12 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions23
Increased31
Decreased35
Sold out12
Institutional Holders
107 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Gordonmd Global Investments LP | 4.24M | $36.63M | −147.0K | Reduced |
| 2 | Gilead Sciences, Inc. | 4.13M | $35.61M | 0 | Held |
| 3 | Bain Capital Life Sciences Investors, LLC | 3.11M | $26.84M | 0 | Held |
| 4 | Deerfield Management Company, L.P. | 2.00M | $17.26M | 0 | Held |
| 5 | Aigh Capital Management LLC | 2.00M | $17.26M | +500.0K | Added |
| 6 | Balyasny Asset Management L.P. | 1.13M | $9.71M | +144.5K | Added |
| 7 | Millennium Management LLC | 1.01M | $8.68M | +412.1K | Added |
| 8 | Insight Holdings Group, LLC | 989.1K | $8.54M | 0 | Held |
| 9 | Morgan Stanley | 977.3K | $8.43M | −25.2K | Reduced |
| 10 | Blackrock, Inc. | 877.1K | $7.57M | +332.5K | Added |
97 more institutional holders on Premium
See every fund holding Kyverna Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders